Delivery Order SPE2DB24D2101-SPE2DB24FKFZB
Award Date
8/19/24
Potential Completion Date
8/20/24
Potential Value
$66K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $35,139.31. The award has a firm fixed price pricing type and an ultimate completion date of July 26, 2024. This contract is not set aside for any specific business category. AmerisourceBergen holds significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 90 mg/mL syringes. The $14,309.70 firm-fixed-price contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of pharmaceutical and medical...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $82,512.87 firm fixed-price contract is for the delivery of STELARA 90 MG/ML syringes. The contract has a period of performance through May 5, 2023 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of STELARA 90 MG/ML SYRINGE syringes. The award, worth $43,968.36, has a firm fixed-price contract type and an ultimate completion date of September 5, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation to provide a wide range of medical...
This is a $116,764.08 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Stelara 90 mg/ml syringes, a specialty pharmaceutical product. The award has an ultimate completion date of August 23, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by defense and civilian...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $14,247.44, is for the supply of 4565634369 - STELARA 45 MG/0.5 ML SYRINGE 0.5ML, a specialty pharmaceutical product. The award is a firm fixed-price delivery order with an ultimate completion date of August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of STELARA 90 MG/ML syringes. The contract award, valued at $7,154.84, has an ultimate completion date of August 7, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,154.84 firm-fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,756.71, is for the delivery of STELARA 90 MG/ML syringes. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of December 26, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $16,930.20, is for the supply of STELARA 90 MG/ML syringes. It is a firm fixed-price contract with an ultimate completion date of August 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers...